Hepatitis C Post-Treatment Follow-Up Program for Private Clinics in Egypt: Keeping Cured Patients in Care
A hepatitis C post-treatment follow-up program is a recall system that keeps patients who finished antiviral treatment attending scheduled checks after cure. It records each patient's liver risk, sets the next due test, reminds the patient, and flags those who miss visits so the clinic can follow up before a gap becomes a missed diagnosis.
Key takeaways
- Cure ends the infection, not the need for follow-up. Published Egyptian studies recommend liver cancer surveillance after cure for patients with advanced fibrosis or cirrhosis.
- The operational risk is attrition: in one Cairo treatment-centre cohort, 292 of 1,333 patients who attended missed their follow-up.
- A clinic does not need new clinical protocols. It needs a registry, risk tiers set by the hepatologist, due dates and a reliable reminder routine.
- Measure attendance and test completion first. Clinical outcome definitions need expert sign-off. HOLD — expert review

On this page
Why cure does not close the file
Egypt has the highest national-level hepatitis C prevalence in the world according to a 2023 Egyptian Journal of Hospital Medicine paper, and direct-acting antivirals are widely used there. Treatment success is now common. What is less visible is what happens to patients afterwards.
The same paper followed patients treated at the New Cairo Viral Hepatitis Treatment Center: 1,333 showed up for follow-up, 1,041 completed it and 292 missed it. Among those who attended, liver tests, platelet count and the FIB-4 fibrosis score improved more than a year after treatment, and the authors advise that people with severe liver disease undergo liver cancer surveillance after sustained virological response (SVR).
Other Egyptian papers point the same way. A 2024 Afro-Egyptian Journal of Infectious and Endemic Diseases study of 440 patients with compensated cirrhosis and SVR notes that guidelines recommend alpha-fetoprotein (AFP) measurement and liver ultrasound every six months in cirrhotic patients with SVR, and that yearly liver cancer risk in HCV cirrhosis is between 2% and 8%. A 2022 prospective study of 1,517 patients with F3 fibrosis at the Egyptian Liver Research Institute and Hospital reported 33 liver cancers during follow-up (0.915 per 100 person-years). A 2022 study of generic antivirals in Egypt found 15.2% of patients had complications during two years of follow-up, with pre-treatment decompensated cirrhosis the main predictor. These are single-centre observational studies. Use them to justify a recall routine, not to quote outcomes to patients. HOLD — expert review
What a private clinic can own
The hepatologist decides who needs which test and when. The clinic owns the reliability of the process: knowing who is due, reaching them, recording results and noticing silence.
Building blocks of the program
1. Build the post-cure registry
Record SVR date, fibrosis stage or score as documented by the treating doctor, cirrhosis status, and relevant comorbidities such as diabetes, obesity or fatty liver. A 2021 study found hepatic steatosis may need attention after antiviral treatment, especially in overweight patients (PubMed 33550979). Entry rules are a clinical decision. HOLD — expert review
2. Assign risk tiers and next-due dates
Ask the hepatologist to define tiers, for example cirrhosis or advanced fibrosis versus lower-risk patients, and the test and interval for each. Typical references are the Egyptian national guidance and international liver societies. The system then generates a due list. Intervals come from guidelines, not from software. HOLD — expert review
3. Make the reminder routine boring and reliable
Send a reminder before the due date through the channel the patient actually answers, usually WhatsApp or a call. Add one follow-up if there is no booking, then a nurse call. Record every attempt. See our guide to WhatsApp appointment reminders for Egyptian clinics for message design.
4. Connect the tests
Ultrasound, AFP and blood tests often sit in different places. Where the lab and radiology centre can send results back, the clinic sees completion rather than assuming it. See our guide to lab and radiology integration.
5. Close the loop on missed visits
A missed follow-up is a task, not a statistic. Assign it to a named person with a deadline. Keep a reason code (changed phone, travelled, cost, felt cured) so you can see what actually drives attrition.
An illustrative scenario (hypothetical)
A three-branch clinic group in Greater Cairo treats a mixed population including patients who completed antiviral treatment elsewhere. The hepatologist defines two tiers and a six-monthly or yearly visit pattern. The clinic loads 600 patients into a registry, sends WhatsApp reminders two weeks before due dates, and gives a nurse a weekly list of patients without a booking. After a quarter the manager reviews the share of registry patients with a current test on file and the main reasons for missed visits. This is a workflow example, not a reported result.
Metrics worth tracking
- Share of registry patients with a documented next-due date.
- Share attending within 30 days of the due date.
- Share of missed visits reached by phone within 7 days.
- Test completion (ultrasound, AFP, blood tests) among attenders.
- Top reasons for non-attendance.
Report clinical outcomes only after definitions and governance are agreed. HOLD — expert review
Privacy and governance
Hepatitis status is sensitive. Limit who can see registry data, avoid disease names in reminder messages, record consent for contact, and check requirements under Egypt's Personal Data Protection Law (Law 151 of 2020) with your counsel. See our guide on patient data privacy under Law 151. [VERIFY WITH BRAND]
Where CareSync Clinic fits
A clinic needs a patient registry, configurable recall rules, reminders in Arabic, result tracking and branch-level reporting. CareSync Clinic is built for single and multi-site clinics; which of these functions are live in your deployment, and which lab or radiology systems it connects to, should be confirmed with the CareSync team. [VERIFY WITH BRAND]
FAQ
What is a hepatitis C post-treatment follow-up program?
A clinic process that keeps patients who finished antiviral treatment attending scheduled checks, with a registry, due dates, reminders and follow-up on missed visits.
Does hepatitis C come back after treatment?
Recurrence and reinfection are clinical questions for the treating doctor. A follow-up program makes sure the patient has a scheduled review rather than relying on memory. HOLD — expert review
Which patients need liver cancer surveillance after cure?
The hepatologist decides. Egyptian studies recommend ultrasound and AFP every six months for cirrhotic patients with SVR; the clinic's role is to keep those appointments from lapsing. HOLD — expert review
What data does a clinic need to start?
SVR date, fibrosis or cirrhosis status as documented by the doctor, comorbidities, contact details with consent, and previous test dates.
Can reminders be sent without revealing the diagnosis?
Yes. Use a neutral message such as "your follow-up visit is due" and keep clinical detail for the consultation. [VERIFY WITH BRAND]
Sources
- Egyptian Journal of Hospital Medicine 2023;90(2):2767-2774, long-term follow-up of chronic hepatitis C patients treated by direct-acting antivirals
- Afro-Egyptian Journal of Infectious and Endemic Diseases 2024;14(2):173-183, HCC among DAA-treated cirrhotic patients with SVR
- Hepatocellular Oncology 2022, hepatic fibrosis and HCC incidence after DAA treatment of F3 patients (ELRIAH)
- American Journal of Tropical Medicine and Hygiene 2022, liver disease outcomes after SVR with generic DAAs (via Epistemonikos)
- Frontiers in Virology 2023, Alashker et al., de novo HCC after HCV eradication
- PubMed 33550979, hepatic steatosis changes after DAAs